my personal edition > pregnancy > news


  E-Mail this DGNews to a colleague

DGNews

Follistim AQ Vial Now Available in 75 IU and 150 IU Presentations

Offers Patients More Flexibility With Fertility Treatment

ROSELAND, NJ -- October 5, 2005 -- Organon Pharmaceuticals Inc USA announces today the availability of Follistim(R) AQ (follitropin beta injection) 75 IU and 150 IU presentations in single-use 0.5 mL vials in pre-mixed solution, therefore eliminating reconstitution.

Follistim(R) AQ is for subcutaneous and intramuscular injection used by patients undergoing assisted reproductive technology procedures, such as IVF and for the induction of ovulation to achieve pregnancy.

"Organon is pleased to provide patients and physicians a full range of fertility medications that can be tailored to meet individual needs. The addition of the Follistim(R) AQ vial in 75 IU and 150 IU presentations complements our existing fertility product portfolio of the Follistim(R) AQ Cartridge in 300 IU, 600 IU and 900 IU strengths which are designed to be used with the Follistim Pen(R)," said Michael Novinski, President, Organon Pharmaceuticals USA Inc. "Through our brands and supporting web sites, Organon is committed to providing integrated programs that meet patient's needs."

Safety Information for Follistim(R) AQ Cartridge and Follistim(R) AQ Vial

-- Follistim(R) AQ Cartridge/Vial, like all gonadotropins, is a potent substance capable of causing mild to severe side effects including OHSS, with or without pulmonary or vascular complications.

-- Follistim(R) AQ Cartridge/Vial, should be prescribed only by physicians who are experienced in infertility treatment and physicians should advise their patients of treatment risks, including OHSS and multiple births.

Safety Information for Follistim(R) AQ Cartridge

-- Follistim(R) AQ Cartridge administered with Follistim Pen(R) delivers on average an 18% higher amount of follitropin beta compared to lyophilized preparations administered with a conventional syringe and needle. A lower dose should be considered when using Follistim(R) AQ Cartridge.


SOURCE: Organon Pharmaceuticals Inc USA

E-Mail this DGNews to a colleague

To print, use this version